Portal de investigación
ESTUDIO DE REDES DE SEÑALES EN OSTEOSARCOMAS.
Datos básicos
- Protocolo:
- SAF2012-37330
- EUDRACT:
- NCT:
- Centro:
- Año de incio:
- 2013
- Año de finalización:
- 2015
Objetivos del proyecto
FAVORABLE
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
Circulating endothelial cells and procoagulant microparticles in patients with glioblastoma: prognostic value.
Reynés G; (...); Martínez-Sales V
Article. 10.1371/journal.pone.0069034. 2013
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition
Sanmartin, E; (...); Font de Mora J
Article. 10.1158/1078-0432.CCR-17-0593. 2017
Distribution of segmental chromosomal alterations in neuroblastoma.
Juan Ribelles A; (...); Castel V
Article. 10.1007/s12094-020-02497-2. 2020
Evaluation of circulating tumor DNA by electropherogram analysis and methylome profiling in high-risk neuroblastomas
Trinidad, Eva Maria; (...); de Mora, Jaime Font
Article. 10.3389/fonc.2023.1037342. 2023
Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Bellini, Angela; (...); Schleiermacher, Gudrun
Article. 10.1200/JCO.21.00086. 2021
Germline Predisposition to Pediatric Cancer, from Next Generation Sequencing to Medical Care.
Gargallo P; (...); Cañete A
Article. 10.3390/cancers13215339. 2021
Germline variant in Ctcf links mental retardation to Wilms tumor predisposition
Gargallo, Pablo; (...); Font de Mora, Jaime
Article. 10.1038/s41431-022-01105-x. 2022
GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
Pérez-Benavente B; (...); Farràs R
Article. 10.1038/onc.2012.235. 2013
Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas
Salvador-Coloma, C; (...); de Mora, JF
Article. 10.2147/OTT.S214319. 2019
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Salvador-Coloma, C; (...); de Mora, JF
Article. 10.1016/j.ejca.2020.08.020. 2020
Immunosuppressive profiles in liquid biopsy predict response to neoadjuvant chemotherapy in triple negative breast cancer
Salvador-Coloma, C; (...); Santaballa, A
Meeting Abstract. 10.1158/1538-7445.SABCS18-P3-11-16. 2019
In silico validation of serum protein profile in long- and short-term glioblastoma survivors: A proteomic approach to prognostic factors
Bruixola, G.; (...); Reynes, G.
Meeting Abstract. 10.1016/S0959-8049(16)31646-X. 2015
Intratumoral immunosuppression profiles in 11q-deleted neuroblastomas provide new potential therapeutic targets.
Coronado, Esther; (...); Font de Mora, Jaime
Article. 10.1002/1878-0261.12868. 2021
Liquid Biopsies of Patients with HIGH-RISK Neuroblastoma Disclose Exosomal miRNA Modulation after the Induction Therapy
Morini, M; (...); Varesio, L
Meeting Abstract. 2017
Liquid Biopsies Provide Exosomal MicroRNAs as Biomarkers of the Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients
Morini, M; (...); Varesio, L
Meeting Abstract. 2018
Liquidhope: methylome and genomic profiling from very limited quantities of plasma-derived DNA.
Trinidad EM; (...); Font de Mora J
Article. 10.1093/bib/bbac575. 2023
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis
Berlanga P; (...); Font de Mora J
Article. 10.1016/j.molonc.2016.04.004. 2016
MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
Olivera, GG; (...); Herrero, MJ
Article. 10.3390/ijms21082714. 2020
Multi-parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review.
Oltra-Sastre M; (...); Garcia-Gomez JM
Article. 10.2174/1573405615666190109100503. 2019
Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas
Ribelles, AJ; (...); Canete, A
Article. 10.3390/jpm11040268. 2021
Pharmacogenetics implementation in the clinics: information and guidelines for germline variants
Olivera, Gladys; (...); Alino, Salvador F.
Review. 10.20517/cdr.2018.25. 2019
Preliminarily results of the Oncohabitats Study: A multicentre validation of overall survival (OS) estimation of patients with glioblastoma (GBM) using vascular biomarkers
Alvarez-Torres, MD; (...); Garcia-Gomez, JM
Meeting Abstract. 10.1158/1538-7445.AM2019-4258. 2019
Publisher Correction: Clinical Features of Neuroblastoma With 11q Deletion: An Increase in Relapse Probabilities In Localized And 4S Stages.
Juan Ribelles A; (...); Castel V
Correction. 10.1038/s41598-020-58428-2. 2020
Robust association between vascular habitats and patient prognosis in glioblastoma: An international multicenter study.
Álvarez-Torres MDM; (...); García-Gómez JM
Article. 10.1002/jmri.26958. 2020
Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis.
Fuentes Q E; (...); Palomo G I
Article. 10.3109/09537104.2012.690113. 2013
Sorting Nexin 6 Enhances Lamin A Synthesis and Incorporation into the Nuclear Envelope
González-Granado JM; (...); Andrés V
Article. 10.1371/journal.pone.0115571. 2014
Targeting neuroblastoma stem cells with retinoic acid and proteasome inhibitor.
Hämmerle B; (...); Font de Mora J
Article. 10.1371/journal.pone.0076761. 2013
The decay of stem cell nourishment at the niche.
Font de Mora J, Díez Juan A
Article. 10.1089/rej.2013.1440. 2013
The Embryonic Key Pluripotent Factor NANOG Mediates Glioblastoma Cell Migration via the SDF1/CXCR4 Pathway.
Sanchez-Sanchez, Ana Virginia; (...); Mullor, Jose Luis
Article. 10.3390/ijms221910620. 2021
The expression of AIB1 correlates with cellular proliferation in human prolactinomas.
Carretero J; (...); Font de Mora J
Article. 10.1016/j.aanat.2013.01.009. 2013
TIAM1 variants improve clinical outcome in neuroblastoma
Sanmartin, E; (...); Font de Mora J
Article. 10.18632/oncotarget.16787. 2017
Tumour growth: An approach to calibrate parameters of a multiphase porous media model based on in vitro observations of Neuroblastoma spheroid growth in a hydrogel microenvironment.
Hervas-Raluy, Silvia; (...); Wall, Wolfgang A.
Article. 10.1016/j.compbiomed.2023.106895. 2023
Two independent epigenetic biomarkers predict survival in neuroblastoma.
Yáñez Y; (...); Castel V
Article. 10.1186/s13148-015-0054-8. 2015
Upregulation of sFRP3 circulating expression levels correlates survival outcomes in glioblastoma
Bruixola, G; (...); Reynes, G
Meeting Abstract. 2019